The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Spatial Organization and Composition of the Mucosal Flora in Patients with Inflammatory Bowel Disease
Open accessAbstract
The composition and spatial organization of the mucosal flora in biopsy specimens from patients with inflammatory bowel disease (IBD; either Crohn's disease or ulcerative colitis), self-limiting colitis, irritable-bowel syndrome (IBS), and healthy controls were investigated by using a broad range of fluorescent bacterial group-specific rRNA-targeted oligonucleotide probes. Each group included 20 subjects. Ten patients who had IBD and who were being treated with antibiotics were also studied. Use of nonaqueous Carnoy fixative to preserve the mucus layer was crucial for detection of bacteria adherent to the mucosal surface (mucosal bacteria). No biofilm was detectable in formalin-fixed biopsy specimens. Mucosal bacteria were found at concentrations greater than 10 9 /ml in 90 to 95% of IBD patients, 95% of patients with self-limiting colitis, 65% of IBS patients, and 35% of healthy controls. The mean density of the mucosal biofilm was 2 powers higher in IBD patients than in patients with IBS or controls, and bacteria were mostly adherent. Bacteroides fragilis was responsible for >60% of the biofilm mass in patients with IBD but for only 30% of the biofilm mass in patients with self-limiting colitis and <15% of the biofilm mass in patients with IBS. In contrast, bacteria which positively hybridized with the probe specific for Eubacterium rectale - Clostridium coccoides accounted for >40% of the biofilm in IBS patients but for <15% of the biofilm in IBD patients. In patients treated with (5-ASA) or antibiotics, the biofilm could be detected with 4,6-diamidino-2-phenylindole but did not hybridize with fluorescence in situ hybridization probes. A Bacteroides fragilis biofilm is the main feature of IBD. This was not previously recognized due to a lack of appropriate tissue fixation. Both 5-ASA and antibiotics suppress but do not eliminate the adherent biofilm.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Spatial niche partitioning of microbial populations can also be a result of mucus from goblet cells 46 and differential oxygen tolerance47.”
From The gut Microbiome in adult and pediatric functional gastrointestinal disorders (2019) · cites this paper as [46]
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Phylogenetic identification and in situ detection of individual microbial cells without cultivation
Amann, R., Ludwig, W., & SCHLEIFER, K. H. (1995) · Microbiological Reviews · doi:10.1128/mr.59.1.143-169.1995 · Cited by 9,218
Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,183
Amann, R., Krumholz, L. R., & Stahl, D. A. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.2.762-770.1990 · Cited by 2,207
Inflammatory bowel disease: Etiology and pathogenesis
Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059
Manz, W., Amann, R., Ludwig, W., Wagner, M., & SCHLEIFER, K. H. (1992) · Systematic and Applied Microbiology · doi:10.1016/s0723-2020(11)80121-9 · Cited by 2,044
Mucosal flora in inflammatory bowel disease
Swidsinski, A. V., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening-Baucke, V. A., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.30294 · Cited by 1,344
Self-citationManz, W., Amann, R., Ludwig, W., Vancanneyt, M., & SCHLEIFER, K. H. (1996) · Microbiology · doi:10.1099/13500872-142-5-1097 · Cited by 1,176
Franks, A. H., Harmsen, H. J. M., Raangs, G. C., Jansen, G. J., Schut, F., & Welling, G. W. (1998) · Applied and Environmental Microbiology · doi:10.1128/aem.64.9.3336-3345.1998 · Cited by 1,056
Langendijk-Genevaux, P. S., Schut, F., Jansen, G. J., Raangs, G. C., Kamphuis, G. R., Wilkinson, M. H. F., & Welling, G. W. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.8.3069-3075.1995 · Cited by 974
Cited by
Sorted by citations
Items 501–600 of 891
Host–microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer
Moossavi, S., Zhang, H., Sun, J., & Rezaei, N. (2013) · Expert Review of Clinical Immunology · doi:10.1586/eci.13.27 · Cited by 27
5-Aminosalicylic Acid and Chemoprevention: Does It Work?
Lopez, A., & Peyrin‐Biroulet, L. (2013) · Digestive Diseases · doi:10.1159/000353806 · Cited by 27
P. aeruginosa interactions with other microbes in biofilms during co-infection
Oliveira, M., Cunha, E. S., Tavares, L. M., & Serrano, I. D. (2023) · AIMS Microbiology · doi:10.3934/microbiol.2023032 · Cited by 31
“For example, biofilms are at least one hundred‐fold more concentrated in biopsies from patients with inflammatory bowel disease compared with those from healthy individuals [57].”
BackgroundPedrogo, D. A. M., Sears, C. L., & Melia, J. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae061 · Cited by 30
Swidsinski, A. V., Loening-Baucke, V. A., Kirsch, S., & Döerffel, Y. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(10)70025-7 · Cited by 26
Self-citationChassaing, B., Garénaux, E., Carrière, J., Rolhion, N., Guérardel, Y., Barnich, N., Bonnet, R., & Darfeuille–Michaud, A. (2015) · Journal of Bacteriology · doi:10.1128/jb.02499-14 · Cited by 26
“Clinical observations show that bacterial biofilms are associated with the mucosa of inflammatory bowel disease (IBD) patients (3).”
Association of gut dysbiosis with intestinal metabolites in response to antibiotic treatment
Khan, T. J., Hasan, M. N., Azhar, E. I., & Yasir, M. (2019) · Human Microbiome Journal · doi:10.1016/j.humic.2018.11.004 · Cited by 26
Gonyar, L. A., Smith, R. M., Girón, J. A., Zachos, N. C., Ruı́z-Pérez, F., & Nataro, J. P. (2020) · Infection and Immunity · doi:10.1128/iai.00176-20 · Cited by 26
“Aqueous fixations, like paraformaldehyde, dehydrate the mucus and result in loss of the mucus layer (28, 29).”
BackgroundResultHanifeh, M., Spillmann, T., Huhtinen, M. K., Sclivagnotis, Y. S., Grönthal, T. S. C., & Hynönen, U. (2021) · Animals · doi:10.3390/ani11113283 · Cited by 26
“Carnoy’s fixative can reportedly be superior to formalin in preserving the mucus layer [45], but we used formalin-fixed and xylene- and ethanol-deparaffinized samples for the quantification of bacteria in a previous study, and demonstrated a largely intact mucus layer in the colonic mucosa of dogs [46].”
Methodvon Klitzing, E., Ekmekçiu, I., Kühl, A. A., Bereswill, S., & Heimesaat, M. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176144 · Cited by 25
Biophysical determinants of biofilm formation in the gut
Arias, S. L., & Brito, I. (2021) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2021.100275 · Cited by 25
Thornton, R. F., Murphy, E. C., Kagawa, T. F., O’Toole, P. W., & Cooney, J. C. (2012) · BMC Microbiology · doi:10.1186/1471-2180-12-190 · Cited by 25
“fragilis cells adhered to epithelial cells in biopsy samples from IBD patients [36,37].”
Le microbiote intestinal humain
Dore, J. M., & Corthier, G. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(10)70002-6 · Cited by 25
Rifaximin for the treatment of irritable bowel syndrome – a drug safety evaluation
Ponziani, F. R., Pecere, S., Lopetuso, L. R., Scaldaferri, F., Cammarota, G., & Gasbarrini, A. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1186639 · Cited by 24
“Finally, the density of bacterial biofilm (a layer of micro-organisms that form a coat on the surface of the intestine) is significantly larger in IBS patients.[16] More recent data have reinforced these observations, showing that the gut microbiota of IBS patients also differs from that of healthy controls in other b…”
ResultRobust Microbial Markers for Non-Invasive Inflammatory Bowel Disease Identification
Wingfield, B., Coleman, S., McGinnity, T. M., & Bjourson, A. J. (2018) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2018.2831212 · Cited by 24
“2 Clostridiales Ruminococcaceae Ruminococcus 2 bromii @[67] 0.”
Han, X., Osuntokun, B., Benight, N. M., Loesch, K. A., Frank, S. J., & Denson, L. A. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060186 · Cited by 25
“It would seem likely that the composition and adherence of the local enteric flora to the epithelium in the proximal colon may interact with local STAT5b activation and the mucosal barrier to regulate PPAR nuclear abundance and susceptibility to colitis.(51,52) Loss of STAT5b may then disrupt this inherent tolerogenic…”
BackgroundBeyond antibiotics: CRISPR/Cas9 triumph over biofilm-associated antibiotic resistance infections
Zuberi, A., Ahmad, N., Ahmad, H., Saeed, M., & Ahmad, I. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1408569 · Cited by 26
Coulombe, G., Langlois, A., Palma, G. D., Langlois, M., McCarville, J. L., Sansfaçon, J. G., Perreault, N., Feng, G., Berčík, P., Boudreau, F., et al. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25407 · Cited by 25
“It is of interest that the changes in microbiota observed in SHP-2 IEC-KO mice are reminiscent of those reported in IBD patients (Lupp et al., 2007; Kostic et al., 2014).”
InfluentialShin, D.-S., Rhee, K., & Eom, Y. (2020) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2001.01027 · Cited by 24
“Recent studies have reported that more than 60% of the biofilms formed by ETBF secreting Bft are frequently found in patients with severe inflammatory diseases [6].”
BackgroundGholam-Mostafaei, F. S., Yadegar, A., Aghdaei, H. A., Azimirad, M., Daryani, N. E., & Zali, M. R. (2020) · Current Research in Translational Medicine · doi:10.1016/j.retram.2020.03.002 · Cited by 24
Inflammation and Gastrointestinal Cancers
Jankowski, J. A. (2011) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-03503-6 · Cited by 24
Park, S., Kim, H., Choi, C. H., Im, J. P., Cha, J. M., Eun, C. S., Kim, T.-O., Kang, S., Bang, K. B., Kim, H. G., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061748 · Cited by 24
“coli, are increased in the mucosa of IBD patients [21,28,29].”
BackgroundTLRs in the Gut. III. Immune responses to flagellin in Crohn's disease: good, bad, or irrelevant?
Gewirtz, A. T. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00347.2006 · Cited by 24
“Specifically, whereas examination of the healthy mucosa has generally found bacteria to be attached to the mucous layer and not in direct contact with the apical membrane of the epithelium, a study (18) in IBD patients observed bacteria very closely opposed and/or directly adherent to the apical membrane and in some c…”
BackgroundImpact of Appendectomy on Gut Microbiota
Бабаханов, А. Т., ДЖУМАБЕКОВ, А. Т., Zhao, A., Kuandykov, Y., Tanabayeva, S. B., Fakhradiyev, I. R., Nazarenko, Y., & Saliev, T. M. (2021) · Surgical Infections · doi:10.1089/sur.2020.422 · Cited by 26
Role of microbiota and related metabolites in gastrointestinal tract barrier function in NAFLD
Fernández-Cantos, M. V., García-Morena, D., Iannone, V., El-Nezami, H. S., Kolehmainen, M., & Kuipers, O. P. (2021) · Tissue Barriers · doi:10.1080/21688370.2021.1879719 · Cited by 23
Pothuraju, R., Pai, P., Chaudhary, S., Siddiqui, J. A., Cox, J. L., Kaur, S., Rachagani, S., Roy, H. K., Bouvet, M., & Batra, S. K. (2022) · Aging · doi:10.18632/aging.203935 · Cited by 23
“The colon has two dramatic mucus layers: the outer (loosely attached) and the inner layer (tightly attached), which is devoid of bacteria [3, 36, 37].”
BackgroundSchnur, S., Wahl, V., Metz, J. K., Gillmann, J., Hans, F., Rotermund, K., Zäh, R., Brück, D. A., Schneider, M., & Hittinger, M. (2022) · In vitro models · doi:10.1007/s44164-022-00035-8 · Cited by 23
“In cases of CD and UC, a high bacterial contamination of the whole mucus layer and the mucosa can be observed [7].”
BackgroundGestational diabetes mellitus: genetic factors, epigenetic alterations, and microbial composition
Lizárraga, D., Gómez‐Gil, B., García-Gasca, T., Ávalos-Soriano, A., Casarini, L., Salazar-Oroz, A., & García-Gasca, A. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02176-y · Cited by 27
“2 Oral, vaginal, and gut microbial composition in women with GDM, showing significant differences in relative abundance according to previous reports positively associated with the presence of inflammatory bowel diseases [171].”
Rejection Reversibly Alters Enteroendocrine Cell Renewal in the Transplanted Small Intestine
Fishbein, T., Novitskiy, G., Lough, D., Matsumoto, C., Kaufman, S. S., Shetty, K., & ZASLOFF, M. A. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02681.x · Cited by 23
“One consequence is the inadequate production of certain AMPs required to prevent microbial access to the epithelium and perhaps to influence the species diversity of the luminal bacteria (24,25).”
BackgroundInteraction between Susceptibility and Environment: Examples from the Digestive Tract
Rogler, G. (2011) · Digestive Diseases · doi:10.1159/000323876 · Cited by 23
“Taken together this would mean that in a genetic susceptible host the normal intestinal flora can enter the mucosal wall without being recognized properly. This may then lead to a defective clearance of bacterial products or even a proliferation in the mucosa. As a consequence, rescue/back-up mechanisms are activated…”
BackgroundDave, M., Johnson, L. A., Walk, S. T., Young, V. B., Stidham, R. W., Chaudhary, M. N., Funnell, J. A., & Higgins, P. (2011) · Gut · doi:10.1136/gut.2010.224337 · Cited by 24
Bušelić, I., Trumbić, Ž., Hrabar, J., Vrbatović, A., Bočina, I., & Mladineo, I. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02055 · Cited by 24
“relationships between microbiota and host correlate with disease states such as inflammatory bowel disease (62).”
BackgroundExploring the Genetic Diversity of the 16S rRNA Gene of Akkermansia Muciniphila in IBD and IBS
Presti, A. L., CHIERICO, F. D., Altomare, A., Zorzi, F., Cella, E., Putignani, L., Guarino, M. P. L., Monteleone, G., Cicala, M., Angeletti, S., et al. (2019) · Future Microbiology · doi:10.2217/fmb-2019-0175 · Cited by 25
Whole brain radiotherapy induces cognitive dysfunction in mice: key role of gut microbiota
Luo, X.-X., Yang, C., Zhan, G.-F., Li, S., Hua, D.-Y., Luo, A.-L., & Yuan, X.-L. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05520-0 · Cited by 23
MAIT cell homing in intestinal homeostasis and inflammation
Wu, Z., Chen, X., Han, F., & Leeansyah, E. (2025) · Science Advances · doi:10.1126/sciadv.adu4172 · Cited by 22
“In addition, the variation in bacterial distribution between the mucus layer and fecal content may also affect MAIT cell positioning and function ( 81 , 84 , 85 ), as different microbial niches within the gut could offer distinct signals for MAIT cell recruitment and retention (Fig.”
Schaefer, A. K., Melnyk, J. E., He, Z., del Rosario, J. F., & Grimes, C. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805417-8.00014-7 · Cited by 22
The cultivable microbiota of the human distal ileum
Villmones, H. C., Halland, A., Stenstad, T., Ulvestad, E., Weedon‐Fekjær, H., & Kommedal, Ø. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.08.021 · Cited by 22
Vecchio, L. E. D., Fiorani, M., Tohumcu, E., Bibbò, S., Porcari, S., Mele, M. C., Pizzoferrato, M., Gasbarrini, A., Cammarota, G., & Ianiro, G. (2022) · Microorganisms · doi:10.3390/microorganisms10071315 · Cited by 22
Recent progress in experimental and human disease-associated multi-species biofilms
Bai, F., Cai, Z., & Yang, L. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.09.010 · Cited by 25
What is the role of the enteric commensal flora in IBD?
Guarner, F. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20548 · Cited by 21
The role of host molecules in communication with the resident and pathogenic microbiota: A review
White, J. R., Dauros-Singorenko, P., Hong, J., Vanholsbeeck, F., Phillips, A., & Swift, S. (2020) · Medicine in Microecology · doi:10.1016/j.medmic.2020.100005 · Cited by 21
Nutrition of Escherichia coli within the intestinal microbiome
Doranga, S., Krogfelt, K. A., Cohen, P. S., & Conway, T. (2024) · EcoSal Plus · doi:10.1128/ecosalplus.esp-0006-2023 · Cited by 23
“Biofilms form in the mucus layers of the mammalian large intestine (164, 165) and our previous research demonstrated that commensal E. coli resides in mixed biofilms in the mouse intestine (83, 84).”
Narrative review on bacteria-derived metabolites in the pathogenesis of ulcerative colitis
Tambovtseva, R. S., ARSLAN, L., Grigoryeva, T., Abdulkhakov, S. R., Doludin, Y. V., Стома, И. О., Rizvanov, A. A., Рифкатовна, М. Р., & Gabdoulkhakova, A. G. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00210-24 · Cited by 23
“At the same time, in IBD, biofilms may contain elevated levels of poten tially protective bacteria, including Bacteroides-Prevotella , B. fragilis, Eubacterium rectale, and Clostridium coccoides (40).”
Bacterial biomechanics—From individual behaviors to biofilm and the gut flora
Ishikawa, T., Omori, T., & Kikuchi, K. (2020) · APL Bioengineering · doi:10.1063/5.0026953 · Cited by 21
“The formation of biofilms also protects the bacterial population from host immune responses and antibiotics by secretion of EPSs and binding bacteria together in layers (Swidsinski et al., 2005).”
BackgroundAn update on the effects of food-derived active peptides on the intestinal microecology
Mu, J., Lin, Q., & Liang, Y. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2094889 · Cited by 21
“An imbalance in the composition or function of the intestinal microbiota can damage the intestinal barrier and trigger abnormal immune responses (Swidsinski et al. 2005).”
BackgroundMicroenvironmental Factors that Shape Bacterial Metabolites in Inflammatory Bowel Disease
Lopez, L. R., Ahn, J.-H., Alves, T., & Arthur, J. C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.934619 · Cited by 23
“coli biofilms are abundant at the mucosa of IBD patients, and genes required for biofilm component biosynthesis are upregulated in IBD patient microbiomes (Swidsinski et al., 2005; Renouf et al., 2018).”
BackgroundZhang, T., Liu, Z., Wang, H., Zhang, H., Li, H., Lu, W., & Zhu, J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1287680 · Cited by 21
Terán-Ventura, E., Roca, M., Martín, M. T., Abarca, M. L., Martı́nez, V., & Vergara, P. (2010) · Microbial Ecology · doi:10.1007/s00248-010-9737-z · Cited by 21
“presence of these commensal bacteria appears to be of crucial importance in the pathogenesis of several gastrointestinal alterations, such as inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS) [8, 37 , 47].”
BackgroundBacterial Flora as a Cause or Treatment of Chronic Diarrhea
Scaldaferri, F., Pizzoferrato, M., Pecere, S., Forte, F., & Gasbarrini, A. (2012) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2012.06.002 · Cited by 21
Munoz, S., Guzmán-Rodríguez, M., Sun, J., Zhang, Y., Noordhof, C., He, S.-M., Allen‐Vercoe, E., Claud, E. C., & Petrof, E. O. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1188248 · Cited by 21
Cazzola, H., Lemaire, L., Acket, S., Prost, E., Duma, L., Erhardt, M., Čechová, P., Trouillas, P., Mohareb, F., Rossi, C., et al. (2020) · Msphere · doi:10.1128/msphere.00702-20 · Cited by 16
Strus, M., Janczyk, A., Gonet-Surówka, A., Brzychczy‐Włoch, M., Stochel, G., Kochan, P., & Pb, H. (2009) · PubMed · Cited by 21
Biswas, T., Ahmed, M. A., & Mondal, S. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106866 · Cited by 23
Adherent-invasive Escherichia coli in Crohn’s disease: the 25th anniversary
Barnich, N., Arthur, J. C., Buisson, A., Campbell, B. J., Carbonnel, F., Chassaing, B., Coombes, B. K., Denizot, J., Dogan, B., Faith, J. J., et al. (2025) · Gut · doi:10.1136/gutjnl-2025-335331 · Cited by 21
Commensal and Pathogenic Escherichia coli Metabolism in the Gut
Conway, T., & Cohen, P. S. (2015) · ASM Press eBooks · doi:10.1128/9781555818883.ch16 · Cited by 22
Colon mucus in colorectal neoplasia and beyond
Loktionov, A. S. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i32.4475 · Cited by 20
Impact of grape polyphenols on Akkermansia muciniphila and the gut barrier
Mezhibovsky, E., Wu, Y., Bawagan, F. G., Tveter, K. M., Szeto, S., & Roopchand, D. E. (2022) · AIMS Microbiology · doi:10.3934/microbiol.2022035 · Cited by 21
Crypt abscess-associated microbiota in inflammatory bowel disease and acute self-limited colitis
Sokol, H. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i5.583 · Cited by 20
Atherly, T. A., Mosher, C., Wang, C., Hostetter, J. M., Proctor, A., Brand, M. W., Phillips, G. J., Wannemuehler, M. J., & Jergens, A. E. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000944 · Cited by 20
Xing, J., Fang, Y., Zhang, W., Zhang, H., Tang, D., & Wang, D. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02738-y · Cited by 17
“fragilis biofilm is widely considered to be a core feature of IBD, as more than 60% of biofilms obtained from IBD patients’ samples contain such bacteria [43].”
BackgroundCho, Y. H., Renouf, M. J. D., Omotoso, O., & McPhee, J. B. (2022) · FEMS Microbiology Letters · doi:10.1093/femsle/fnac098 · Cited by 19
Focus on irritable bowel syndrome.
Scalera, A., & Loguercio, C. (2012) · PubMed · Cited by 19
Intestinal dysbiosis in irritable bowel syndrome: etiological factor or epiphenomenon?
Cremon, C., Carini, G., GIORGIO, R. D., Stanghellini, V., Corinaldesi, R., & Barbara, G. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.33 · Cited by 19
Rewiring of the cellular and inter-cellular landscape of the human colon during ulcerative colitisPreprint
Smillie, C. S., Biton, M., Ordovás-Montañés, J., Sullivan, K. M., Burgin, G., Graham, D. B., Herbst, R. H., Rogel, N., Slyper, M., Waldman, J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/455451 · Cited by 18
“Within the colon, pH and sour taste sensing may help detect members of the gut microbiota, for example, the Lactobacillales, which have established long-term symbioses with humans and inhabit colonic crypts [82].”
BackgroundArase, S., Watanabe, Y., Setoyama, H., Nagaoka, N., Kawai, M., & Matsumoto, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160736 · Cited by 18
“Exacerbation of gut inflammation by chronic psychological stress It was reported that Tcra mice spontaneously develop human UC-like colitis, which may be due to a deregulated mucosal immune system evoked by the GI microbiota [14, 38].”
BackgroundWilling, B., Halfvarson, J., Dicksved, J., Rosenquist, M., Järnerot, G., Engstrand, L., Tysk, C., & Jansson, J. K. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20783 · Cited by 455
“Reports of increased bacterial numbers associated with biopsies from CD patients as compared to healthy controls have been inconsistent.(47,50,51) We did not observe any differences in bacterial numbers associated with disease phenotype, however, this may be due to the nature of the control patients, as”
BackgroundMucosa-associated bacteria and metabolites in inflammatory bowel disease: from inside to insight
Wang, X., He, L., Dong, Y., Qin, X., Zhang, H., Wang, B., Wang, S., & Cao, H. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00887-4 · Cited by 21
RETRACTED ARTICLE: Gut microbiota and related diseases: clinical features
Stanghellini, V., Barbara, G., Cremon, C., Cogliandro, R. F., Antonucci, A., Gabusi, V., Frisoni, C., GIORGIO, R. D., Grasso, V., Serra, M., et al. (2010) · Internal and Emergency Medicine · doi:10.1007/s11739-010-0451-0 · Cited by 18
“the mucosal layer were higher in IBS (65%) compared with controls (35%) [ 30 ].”
ResultRetractedZangara, M. T., Darwish, L., & Coombes, B. K. (2023) · EcoSal Plus · doi:10.1128/ecosalplus.esp-0018-2022 · Cited by 19
Single-cell analysis and spatial resolution of the gut microbiome
Madhu, B., Miller, B. M., & Levy, M. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1271092 · Cited by 18
Fagundes, C. T., Souza, D. G., Nicoli, J. R., & Teixeira, M. M. (2011) · Microbes and Infection · doi:10.1016/j.micinf.2011.07.012 · Cited by 18
Knoch, B., Nones, K., Barnett, M. P. G., McNabb, W. C., & Roy, N. C. (2010) · Microbiology · doi:10.1099/mic.0.041723-0 · Cited by 18
Souza, D. G., Senchenkova, E. Y., Russell, J., & Granger, D. N. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000331 · Cited by 18
“These changes include reduced bacterial diversity, decreased levels of resident Firmicutes and/or Bacteroidetes, an overgrowth of Proteobacteria, and abnormal adherence of bacteria to the gut mucosa.(50,51) To avoid the microbiota disturbance in this study, we recolonized GF mice with feces derived from Souza et al In…”
MethodAntibiofilm and antibacterial activities of repurposing auranofin against Bacteroides fragilis
Jang, H.-I., & Eom, Y. (2019) · Archives of Microbiology · doi:10.1007/s00203-019-01764-3 · Cited by 18
Kappler, K., Lasanajak, Y., Smith, D. F., Opitz, L., & Hennet, T. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01553 · Cited by 17
“Bacteroides Fucosylation and Recognition by IgG in CD Patients Bacteroidetes is a major phylum of the human intestinal microbiota and several Bacteroides species have been found to be enriched in IBD (Swidsinski et al., 2005; Gevers et al., 2014).”
BackgroundImpact of the ileal microbiota on colon cancer
Roberti, M. P., Rauber, C., Kroemer, G., & Zitvogel, L. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.09.016 · Cited by 18
Friendly pathogens: prevent or provoke autoimmunity
Sathyabama, S., Khan, N., & Agrewala, J. N. (2013) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2013.787043 · Cited by 18
“However, the human intestine is dominated by bacteroidetes and firmicutes, which represents more than two-thirds of the total gut microbiota (Frank et al., 2007; Swidsinski et al., 2005).”
BackgroundHarrington, C. R., Lucchini, S., Ridgway, K. P., Wegmann, U., Eaton, T. J., Hinton, J. C. D., Gasson, M. J., & Narbad, A. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-195 · Cited by 18
“It is estimated that more than one million Americans have UC or Crohn's disease (CD), the two most common forms of Inflammatory Bowel Disease (IBD) [45].”
Lough, D., Abdo, J., Guerra-Castro, J. F., Matsumoto, C., Kaufman, S. S., Shetty, K., Kwon, Y., ZASLOFF, M. A., & Fishbein, T. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03897.x · Cited by 18
“(20,21) using the “universal” bacterial nucleic acid probe EUB338, which targets the 16S rRNA of bacteria.”
MethodBeresford-Jones, B. S., Suyama, S., Clare, S., Soderholm, A. T., Xia, W., Sardar, P., Lee, J., Harcourt, K., Lawley, T. D., & Pedicord, V. A. (2025) · Microbiome · doi:10.1186/s40168-025-02050-9 · Cited by 17
Parker, K. D., Mueller, J. L., Westfal, M. L., Goldstein, A. M., & Ward, N. L. (2022) · Pediatric Surgery International · doi:10.1007/s00383-022-05191-2 · Cited by 18
Flagellin is essential for initial attachment to mucosal surfaces by Clostridioides difficile
Sidner, B. S., Lerma, A. I., Biswas, B., Do, T. V. T., Yu, Y., Ronish, L. A., McCullough, H. C., Auchtung, J. M., & Piepenbrink, K. H. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02120-23 · Cited by 16
“However, tissue fixation with Carnoy’s fixative or paraformaldehyde has allowed for better preservation of mucous structure (15, 16) and microscopic observation of bacterial species localized to this region of the mucosa.”
BackgroundImmunomodulation of periodontitis with SPMs
Sahni, V., & Dyke, T. E. V. (2023) · Frontiers in Oral Health · doi:10.3389/froh.2023.1288722 · Cited by 20
Nuding, S., Antoni, L., & Stange, E. F. (2013) · Digestive Diseases · doi:10.1159/000354680 · Cited by 20
Emergent Behavior of IBD-AssociatedEscherichia coliDuring Disease
Renouf, M. J. D., Cho, Y. H., & McPhee, J. B. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy312 · Cited by 16
Odun-Ayo, F., & Reddy, L. (2022) · Gastroenterology Insights · doi:10.3390/gastroent13010006 · Cited by 18
Watts, J. E. M., McDonald, R. C., Daniel, R., & Schreier, H. J. (2013) · Diversity · doi:10.3390/d5030641 · Cited by 17
“Attempts to visualize a mucus-associated community in 4% paraformaldehyde-fixed tissues were unsuccessful, which may be explained by the inability of formaldehyde-based fixatives to preserve mucus [49].”
BackgroundA Bacteroides fragilis protease activates host PAR2 to induce intestinal pain and inflammation
Lakemeyer, M., Latorre, R., Blažková, K., Wood, H. M., Jensen, D. D., Shakil, N., Thomas, S. C., Saxena, D. B., Mulpuri, Y., Poolman, D., et al. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.09.010 · Cited by 26
Rana, T., Korolkova, O. Y., Rachakonda, G., Williams, A. D., Hawkins, A. T., James, S. D., Sakwe, A. M., Nian, H., Wang, L., Yu, C. S., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246393 · Cited by 16
The role of gut microbiota in the treatment of irritable bowel syndrome
Leylabadlo, H. E., Heravi, F. S., Soltani, E., Abbasi, A., Kafil, H. S., Parsaei, M., Sanaie, S., Ahmadian, Z., & Ghotaslou, R. (2021) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000284 · Cited by 16
“Higher and lower [133,140] Flavobacteria Lower [141] Prevotella Lower [142] Proteobacteria Escherichia Higher [87] Desulfovibrio spp.”
BackgroundKhafipour, A., Eissa, N., Munyaka, P. M., Rabbi, M. F., Kapoor, K., Kermarrec, L., Khafipour, E., Bernstein, C. N., & Ghia, J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01405 · Cited by 19
Bretto, E., D’Amico, F., Fiore, W., Tursi, A., & Danese, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11071916 · Cited by 19
“016) known for its role in the etiopathogenesis of IBS [73,84,85].”
BackgroundInfluentialPlissonneau, C., Sivignon, A., Chassaing, B., Capel, F., Martin, V., Etienne, M., Wawrzyniak, I., Chaussé, P., Dutheil, F., Mairesse, G., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115891 · Cited by 21
Microbial networking in cancer: when two toxins collide
Tomkovich, S., & Jobin, C. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0101-2 · Cited by 16
Biofilms: A cause for the development of cancer: A review
Gupta, A., Bhattacharya, D., Elayaperumal, S., Sivamani, Y., Lahiri, D., & Nag, M. (2025) · The Microbe · doi:10.1016/j.microb.2025.100236 · Cited by 15
Fecal microbiota transplantation refurbishes the crypt-associated microbiota in ulcerative colitis
Markandey, M., Bajaj, A., Verma, M., Virmani, S., Singh, M. K., Gaur, P., Das, P., Srikanth, C. V., Makharia, G. K., Kedia, S., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106738 · Cited by 15
“Initial reports provided fluorescence images that proved bacterial colonization of the crypt region and also went on to analyze quantitative variation in crypt colonization between healthy and inflamedmucosal tissue.(3,4) The composition of the crypt-resident community, however, was still unexplored.”
BackgroundThe Role of the Gut Microbiome in Inflammatory Bowel Disease: The Middle East Perspective
El-Sayed, A., Kapila, D., Taha, R. S. I., El-Sayed, S., Mahen, M. R. A., Taha, R., & Alrubaiy, L. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14060652 · Cited by 17
“Colonic epithelium in CD has been shown to harbour biofilms dominated by Bacteriodes fragilis , Enterobacteriaceae , Helicobacter pylori , Pseudomonas aeruginosa , and E. coli [55].”
BackgroundSwidsinski, A. V., Amann, R., Guschin, A. E., Swidsinski, S., Loening-Baucke, V. A., Mendling, W., Sobel, J. D., Lamont, R., Vaneechoutte, M., Vieira‐Baptista, P., et al. (2024) · Microbes and Infection · doi:10.1016/j.micinf.2024.105403 · Cited by 15
Self-citationKHAN, I. A., Bai, Y., Ullah, N., Liu, G., Rajoka, M. S. R., & Zhang, C. (2022) · Advanced Gut & Microbiome Research · doi:10.1155/2022/7813278 · Cited by 17
“Furthermore, the key evidence that determines the gut microbiota involvement in IBD development comes from antibiotic use in IBD patients and animal colitis models [18, 19], colitis development in wild-type mice with microbiota transfer from colitis-bearing mice [20], and colitis development in germ-free mice with ino…”
BackgroundBraun, A., Schönfeld, U., Welsch, T., Kadmon, M., Funke, B., Gotthardt, D. N., Zahn, A., Autschbach, F., Kienle, P., Zharnikov, M., et al. (2011) · International Journal of Colorectal Disease · doi:10.1007/s00384-011-1190-z · Cited by 15
Metadata
- Authors
- Swidsinski, A., Weber, J., Loening-Baucke, V., Hale, L. P., & Lochs, H.
- Affiliations
- Humboldt-Universität zu Berlin (DE)
- Duke Medical Center (US)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2005-07
- Volume
- 43
- Issue
- 7
- Pages
- 3380-3389
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC1169142
- OpenAlex
- W2097177097
- Cited by
- 894
- References
- 36
- Citations by year
- 2026: 15 · 2025: 27 · 2024: 45 · 2023: 47 · 2022: 59 · 2021: 47 · 2020: 50 · 2019: 54 · 2018: 46 · 2017: 35 · 2016: 47 · 2015: 49 · 2014: 41 · 2013: 43 · 2012: 44
- FWCI
- 12.71
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli and Edythe Broad Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- inflammatory bowel disease, Crohn's disease, ulcerative colitis, Bacteroides fragilis, irritable bowel syndrome, 5-aminosalicylic acid, antibiotic therapy, bacterial adhesion, fluorescence in situ hybridization, rRNA-targeted oligonucleotide probes
- MeSH terms
- Adult, Bacteria, Bacteroides fragilis, Biopsy, Colitis, Ulcerative, Crohn Disease, Female, Humans, Intestinal Mucosa, Male, Middle Aged, Colon, Sigmoid, In Situ Hybridization, Fluorescence, Ecosystem, Biofilms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review